“GERD is common, affecting about 20 percent of adults in the U.S., and it can compromise quality of life and have serious, long-term health consequences if not addressed and treated properly,” said Annie Laurie Benzie, M.D., a fellowship-trained, board-certified general surgeon who leads the new program.
When chest pain isn’t a heart attack
The second most common reason adults in the United States go to the emergency department is chest pain, yet more than half of those visits have noncardiac
Mayo Clinic Healthcare expert explains when swallowing issues are more than an accident
Many people have experienced the discomfort of food or a beverage accidentally going to the wrong place when swallowing. But swallowing issues sometimes become chronic and may be a sign of a health condition that should be treated.
January Issue of The American Journal of Gastroenterology Includes New Clinical Guideline on Irritable Bowel Syndrome
The January issue of The American Journal of Gastroenterology is now available and features new clinical research across a wide range of GI and hepatology topics, including NAFLD, colorectal cancer screening, GERD, post-COVID-19-associated functional GI disorder surges, celiac disease, and more.
Potential New Heartburn Drug Studied at VUMC
An investigational drug that binds bile acids in the stomach can reduce the severity of heartburn symptoms in patients with treatment-resistant gastroesophageal reflux disease (GERD) when combined with a proton pump inhibitor (PPI), a new study suggests.
Tips for enjoying your holiday meal while managing GERD
Experts from the University of Chicago Medicine Center for Esophageal Diseases share their tips on how to celebrate Thanksgiving without feeling the sting of acid reflux.
New Research Could Change Clinical Practice for Cases of Unmanaged Heartburn
A study published today in The New England Journal of Medicine found that in patients seen for heartburn unresponsive to treatment with Proton Pump Inhibitors (PPIs), an extensive, systematic workup revealed truly PPI-refractory and reflux-related heartburn in only a minority of cases. In other words, most patients with heartburn unrelieved by PPIs did not have gastroesophageal reflux disease (GERD) causing the symptom. Furthermore, for the selected subgroup identified as having reflux-related, PPI-refractory heartburn, surgery that corrects reflux was significantly superior (67% success rate) to continued medical therapy (28% success rate).